nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2C9—Capecitabine—esophageal cancer	0.117	0.407	CbGbCtD
Modafinil—CYP2B6—Cisplatin—esophageal cancer	0.112	0.388	CbGbCtD
Modafinil—CYP2C9—Cisplatin—esophageal cancer	0.0591	0.205	CbGbCtD
Modafinil—Nepafenac—PTGS1—esophageal cancer	0.00202	0.102	CrCbGaD
Modafinil—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00179	0.00528	CcSEcCtD
Modafinil—Polyuria—Capecitabine—esophageal cancer	0.00179	0.00526	CcSEcCtD
Modafinil—Photosensitivity—Capecitabine—esophageal cancer	0.00179	0.00526	CcSEcCtD
Modafinil—Gastroenteritis—Capecitabine—esophageal cancer	0.00177	0.00521	CcSEcCtD
Modafinil—Pancytopenia—Cisplatin—esophageal cancer	0.00175	0.00514	CcSEcCtD
Modafinil—Herpes simplex—Methotrexate—esophageal cancer	0.00174	0.00514	CcSEcCtD
Modafinil—Eye pain—Capecitabine—esophageal cancer	0.00174	0.00512	CcSEcCtD
Modafinil—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.0017	0.00501	CcSEcCtD
Modafinil—Libido decreased—Capecitabine—esophageal cancer	0.00169	0.00498	CcSEcCtD
Modafinil—Oxaprozin—PTGS1—esophageal cancer	0.00168	0.0845	CrCbGaD
Modafinil—Amnesia—Capecitabine—esophageal cancer	0.00167	0.00492	CcSEcCtD
Modafinil—Increased appetite—Capecitabine—esophageal cancer	0.00167	0.00492	CcSEcCtD
Modafinil—Thirst—Capecitabine—esophageal cancer	0.00165	0.00485	CcSEcCtD
Modafinil—Bifonazole—CYP19A1—esophageal cancer	0.00164	0.0828	CrCbGaD
Modafinil—Arthritis—Capecitabine—esophageal cancer	0.00161	0.00475	CcSEcCtD
Modafinil—Stomatitis—Cisplatin—esophageal cancer	0.0016	0.00471	CcSEcCtD
Modafinil—Conjunctivitis—Cisplatin—esophageal cancer	0.00159	0.00469	CcSEcCtD
Modafinil—Cystitis noninfective—Methotrexate—esophageal cancer	0.00157	0.00463	CcSEcCtD
Modafinil—Osteoarthritis—Capecitabine—esophageal cancer	0.00157	0.00462	CcSEcCtD
Modafinil—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00156	0.00458	CcSEcCtD
Modafinil—Cystitis—Methotrexate—esophageal cancer	0.00155	0.00457	CcSEcCtD
Modafinil—Migraine—Capecitabine—esophageal cancer	0.00154	0.00455	CcSEcCtD
Modafinil—Bradycardia—Cisplatin—esophageal cancer	0.0015	0.00441	CcSEcCtD
Modafinil—Irritability—Capecitabine—esophageal cancer	0.0015	0.00441	CcSEcCtD
Modafinil—Cardiac arrest—Capecitabine—esophageal cancer	0.00149	0.00439	CcSEcCtD
Modafinil—Urinary retention—Capecitabine—esophageal cancer	0.00149	0.00439	CcSEcCtD
Modafinil—Mood swings—Capecitabine—esophageal cancer	0.00149	0.00438	CcSEcCtD
Modafinil—Ataxia—Capecitabine—esophageal cancer	0.00147	0.00434	CcSEcCtD
Modafinil—Ecchymosis—Methotrexate—esophageal cancer	0.00145	0.00428	CcSEcCtD
Modafinil—Bladder pain—Methotrexate—esophageal cancer	0.00145	0.00428	CcSEcCtD
Modafinil—Mouth ulceration—Methotrexate—esophageal cancer	0.00145	0.00428	CcSEcCtD
Modafinil—Urine output increased—Methotrexate—esophageal cancer	0.00145	0.00428	CcSEcCtD
Modafinil—Urinary tract disorder—Cisplatin—esophageal cancer	0.00145	0.00428	CcSEcCtD
Modafinil—Connective tissue disorder—Cisplatin—esophageal cancer	0.00145	0.00426	CcSEcCtD
Modafinil—Urethral disorder—Cisplatin—esophageal cancer	0.00144	0.00425	CcSEcCtD
Modafinil—Dry skin—Capecitabine—esophageal cancer	0.00144	0.00423	CcSEcCtD
Modafinil—Abdominal pain upper—Capecitabine—esophageal cancer	0.00143	0.00422	CcSEcCtD
Modafinil—Visual impairment—Cisplatin—esophageal cancer	0.00142	0.00418	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.00141	0.00416	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00141	0.00416	CcSEcCtD
Modafinil—Fenoprofen—PTGS1—esophageal cancer	0.00139	0.0699	CrCbGaD
Modafinil—Muscular weakness—Capecitabine—esophageal cancer	0.00138	0.00407	CcSEcCtD
Modafinil—Cardiac disorder—Cisplatin—esophageal cancer	0.00137	0.00402	CcSEcCtD
Modafinil—Influenza—Capecitabine—esophageal cancer	0.00136	0.00399	CcSEcCtD
Modafinil—Asthma—Capecitabine—esophageal cancer	0.00136	0.00399	CcSEcCtD
Modafinil—Polyuria—Methotrexate—esophageal cancer	0.00133	0.00392	CcSEcCtD
Modafinil—Photosensitivity—Methotrexate—esophageal cancer	0.00133	0.00392	CcSEcCtD
Modafinil—Immune system disorder—Cisplatin—esophageal cancer	0.00133	0.00392	CcSEcCtD
Modafinil—Mediastinal disorder—Cisplatin—esophageal cancer	0.00133	0.00391	CcSEcCtD
Modafinil—Arrhythmia—Cisplatin—esophageal cancer	0.00131	0.00387	CcSEcCtD
Modafinil—Bronchitis—Capecitabine—esophageal cancer	0.0013	0.00384	CcSEcCtD
Modafinil—Pancytopenia—Capecitabine—esophageal cancer	0.00129	0.00379	CcSEcCtD
Modafinil—Malnutrition—Cisplatin—esophageal cancer	0.00128	0.00377	CcSEcCtD
Modafinil—Flatulence—Cisplatin—esophageal cancer	0.00126	0.00372	CcSEcCtD
Modafinil—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00124	0.00364	CcSEcCtD
Modafinil—Levomethadyl Acetate—CYP19A1—esophageal cancer	0.00124	0.0623	CrCbGaD
Modafinil—Weight increased—Capecitabine—esophageal cancer	0.00123	0.00363	CcSEcCtD
Modafinil—Muscle spasms—Cisplatin—esophageal cancer	0.00123	0.00363	CcSEcCtD
Modafinil—Weight decreased—Capecitabine—esophageal cancer	0.00123	0.00361	CcSEcCtD
Modafinil—Hyperglycaemia—Capecitabine—esophageal cancer	0.00122	0.0036	CcSEcCtD
Modafinil—Pneumonia—Capecitabine—esophageal cancer	0.00122	0.00358	CcSEcCtD
Modafinil—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00121	0.00355	CcSEcCtD
Modafinil—Depression—Capecitabine—esophageal cancer	0.0012	0.00355	CcSEcCtD
Modafinil—Tremor—Cisplatin—esophageal cancer	0.0012	0.00354	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.0012	0.00353	CcSEcCtD
Modafinil—Ill-defined disorder—Cisplatin—esophageal cancer	0.00119	0.0035	CcSEcCtD
Modafinil—Anaemia—Cisplatin—esophageal cancer	0.00118	0.00349	CcSEcCtD
Modafinil—Stomatitis—Capecitabine—esophageal cancer	0.00118	0.00347	CcSEcCtD
Modafinil—Urinary tract infection—Capecitabine—esophageal cancer	0.00117	0.00346	CcSEcCtD
Modafinil—Conjunctivitis—Capecitabine—esophageal cancer	0.00117	0.00346	CcSEcCtD
Modafinil—Osteoarthritis—Methotrexate—esophageal cancer	0.00117	0.00344	CcSEcCtD
Modafinil—Malaise—Cisplatin—esophageal cancer	0.00116	0.0034	CcSEcCtD
Modafinil—Nepafenac—PTGS2—esophageal cancer	0.00115	0.0582	CrCbGaD
Modafinil—Haematuria—Capecitabine—esophageal cancer	0.00115	0.00339	CcSEcCtD
Modafinil—Epistaxis—Capecitabine—esophageal cancer	0.00114	0.00336	CcSEcCtD
Modafinil—Agranulocytosis—Capecitabine—esophageal cancer	0.00113	0.00332	CcSEcCtD
Modafinil—Irritability—Methotrexate—esophageal cancer	0.00111	0.00328	CcSEcCtD
Modafinil—Convulsion—Cisplatin—esophageal cancer	0.00111	0.00327	CcSEcCtD
Modafinil—Phenylbutazone—PTGS1—esophageal cancer	0.00111	0.0559	CrCbGaD
Modafinil—Mood swings—Methotrexate—esophageal cancer	0.00111	0.00326	CcSEcCtD
Modafinil—Bradycardia—Capecitabine—esophageal cancer	0.0011	0.00325	CcSEcCtD
Modafinil—Cinnarizine—CYP2A6—esophageal cancer	0.0011	0.0553	CrCbGaD
Modafinil—Ataxia—Methotrexate—esophageal cancer	0.0011	0.00323	CcSEcCtD
Modafinil—Myalgia—Cisplatin—esophageal cancer	0.00109	0.00321	CcSEcCtD
Modafinil—Rhinitis—Capecitabine—esophageal cancer	0.00109	0.0032	CcSEcCtD
Modafinil—Anxiety—Cisplatin—esophageal cancer	0.00109	0.0032	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00108	0.00319	CcSEcCtD
Modafinil—Discomfort—Cisplatin—esophageal cancer	0.00108	0.00317	CcSEcCtD
Modafinil—Pharyngitis—Capecitabine—esophageal cancer	0.00108	0.00317	CcSEcCtD
Modafinil—Urinary tract disorder—Capecitabine—esophageal cancer	0.00107	0.00316	CcSEcCtD
Modafinil—Oedema peripheral—Capecitabine—esophageal cancer	0.00107	0.00315	CcSEcCtD
Modafinil—Connective tissue disorder—Capecitabine—esophageal cancer	0.00107	0.00314	CcSEcCtD
Modafinil—Urethral disorder—Capecitabine—esophageal cancer	0.00106	0.00313	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.00105	0.0031	CcSEcCtD
Modafinil—Carbamazepine—ABCC2—esophageal cancer	0.00105	0.0528	CrCbGaD
Modafinil—Anaphylactic shock—Cisplatin—esophageal cancer	0.00105	0.00308	CcSEcCtD
Modafinil—Oedema—Cisplatin—esophageal cancer	0.00105	0.00308	CcSEcCtD
Modafinil—Visual impairment—Capecitabine—esophageal cancer	0.00105	0.00308	CcSEcCtD
Modafinil—Infection—Cisplatin—esophageal cancer	0.00104	0.00306	CcSEcCtD
Modafinil—Erythema multiforme—Capecitabine—esophageal cancer	0.00103	0.00302	CcSEcCtD
Modafinil—Nervous system disorder—Cisplatin—esophageal cancer	0.00103	0.00302	CcSEcCtD
Modafinil—Tachycardia—Cisplatin—esophageal cancer	0.00102	0.00301	CcSEcCtD
Modafinil—Phenytoin—ABCC2—esophageal cancer	0.00102	0.0513	CrCbGaD
Modafinil—Skin disorder—Cisplatin—esophageal cancer	0.00102	0.00299	CcSEcCtD
Modafinil—Hyperhidrosis—Cisplatin—esophageal cancer	0.00101	0.00298	CcSEcCtD
Modafinil—Asthma—Methotrexate—esophageal cancer	0.00101	0.00297	CcSEcCtD
Modafinil—Cardiac disorder—Capecitabine—esophageal cancer	0.00101	0.00297	CcSEcCtD
Modafinil—Eosinophilia—Methotrexate—esophageal cancer	0.000999	0.00294	CcSEcCtD
Modafinil—Anorexia—Cisplatin—esophageal cancer	0.000997	0.00294	CcSEcCtD
Modafinil—Angiopathy—Capecitabine—esophageal cancer	0.000984	0.0029	CcSEcCtD
Modafinil—Immune system disorder—Capecitabine—esophageal cancer	0.00098	0.00289	CcSEcCtD
Modafinil—Mediastinal disorder—Capecitabine—esophageal cancer	0.000978	0.00288	CcSEcCtD
Modafinil—Hypotension—Cisplatin—esophageal cancer	0.000977	0.00288	CcSEcCtD
Modafinil—Chills—Capecitabine—esophageal cancer	0.000973	0.00287	CcSEcCtD
Modafinil—Arrhythmia—Capecitabine—esophageal cancer	0.000969	0.00285	CcSEcCtD
Modafinil—Oxaprozin—PTGS2—esophageal cancer	0.00096	0.0483	CrCbGaD
Modafinil—Pancytopenia—Methotrexate—esophageal cancer	0.000958	0.00282	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000952	0.00281	CcSEcCtD
Modafinil—Mental disorder—Capecitabine—esophageal cancer	0.00095	0.0028	CcSEcCtD
Modafinil—Malnutrition—Capecitabine—esophageal cancer	0.000944	0.00278	CcSEcCtD
Modafinil—Paraesthesia—Cisplatin—esophageal cancer	0.000939	0.00277	CcSEcCtD
Modafinil—Dyspnoea—Cisplatin—esophageal cancer	0.000932	0.00275	CcSEcCtD
Modafinil—Flatulence—Capecitabine—esophageal cancer	0.00093	0.00274	CcSEcCtD
Modafinil—Erectile dysfunction—Methotrexate—esophageal cancer	0.000929	0.00274	CcSEcCtD
Modafinil—Dysgeusia—Capecitabine—esophageal cancer	0.000925	0.00272	CcSEcCtD
Modafinil—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000921	0.00271	CcSEcCtD
Modafinil—Back pain—Capecitabine—esophageal cancer	0.000913	0.00269	CcSEcCtD
Modafinil—Decreased appetite—Cisplatin—esophageal cancer	0.000909	0.00268	CcSEcCtD
Modafinil—Muscle spasms—Capecitabine—esophageal cancer	0.000908	0.00267	CcSEcCtD
Modafinil—Pneumonia—Methotrexate—esophageal cancer	0.000905	0.00267	CcSEcCtD
Modafinil—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000903	0.00266	CcSEcCtD
Modafinil—Drowsiness—Methotrexate—esophageal cancer	0.000899	0.00265	CcSEcCtD
Modafinil—Depression—Methotrexate—esophageal cancer	0.000897	0.00264	CcSEcCtD
Modafinil—Pain—Cisplatin—esophageal cancer	0.000894	0.00263	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000892	0.00263	CcSEcCtD
Modafinil—Tremor—Capecitabine—esophageal cancer	0.000885	0.00261	CcSEcCtD
Modafinil—Stomatitis—Methotrexate—esophageal cancer	0.000877	0.00258	CcSEcCtD
Modafinil—Ill-defined disorder—Capecitabine—esophageal cancer	0.000876	0.00258	CcSEcCtD
Modafinil—Conjunctivitis—Methotrexate—esophageal cancer	0.000874	0.00258	CcSEcCtD
Modafinil—Anaemia—Capecitabine—esophageal cancer	0.000873	0.00257	CcSEcCtD
Modafinil—Sweating—Methotrexate—esophageal cancer	0.000862	0.00254	CcSEcCtD
Modafinil—Feeling abnormal—Cisplatin—esophageal cancer	0.000861	0.00254	CcSEcCtD
Modafinil—Haematuria—Methotrexate—esophageal cancer	0.000858	0.00253	CcSEcCtD
Modafinil—Malaise—Capecitabine—esophageal cancer	0.000852	0.00251	CcSEcCtD
Modafinil—Epistaxis—Methotrexate—esophageal cancer	0.000848	0.0025	CcSEcCtD
Modafinil—Vertigo—Capecitabine—esophageal cancer	0.000848	0.0025	CcSEcCtD
Modafinil—Syncope—Capecitabine—esophageal cancer	0.000847	0.00249	CcSEcCtD
Modafinil—Agranulocytosis—Methotrexate—esophageal cancer	0.000839	0.00247	CcSEcCtD
Modafinil—Palpitations—Capecitabine—esophageal cancer	0.000834	0.00246	CcSEcCtD
Modafinil—Loss of consciousness—Capecitabine—esophageal cancer	0.00083	0.00244	CcSEcCtD
Modafinil—Body temperature increased—Cisplatin—esophageal cancer	0.000826	0.00243	CcSEcCtD
Modafinil—Cough—Capecitabine—esophageal cancer	0.000824	0.00243	CcSEcCtD
Modafinil—Ketoprofen—PTGS1—esophageal cancer	0.000819	0.0412	CrCbGaD
Modafinil—Hypertension—Capecitabine—esophageal cancer	0.000815	0.0024	CcSEcCtD
Modafinil—Myalgia—Capecitabine—esophageal cancer	0.000804	0.00237	CcSEcCtD
Modafinil—Arthralgia—Capecitabine—esophageal cancer	0.000804	0.00237	CcSEcCtD
Modafinil—Chest pain—Capecitabine—esophageal cancer	0.000804	0.00237	CcSEcCtD
Modafinil—Pharyngitis—Methotrexate—esophageal cancer	0.000801	0.00236	CcSEcCtD
Modafinil—Anxiety—Capecitabine—esophageal cancer	0.000801	0.00236	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000798	0.00235	CcSEcCtD
Modafinil—Urinary tract disorder—Methotrexate—esophageal cancer	0.000797	0.00235	CcSEcCtD
Modafinil—Discomfort—Capecitabine—esophageal cancer	0.000794	0.00234	CcSEcCtD
Modafinil—Fenoprofen—PTGS2—esophageal cancer	0.000793	0.0399	CrCbGaD
Modafinil—Urethral disorder—Methotrexate—esophageal cancer	0.000792	0.00233	CcSEcCtD
Modafinil—Dry mouth—Capecitabine—esophageal cancer	0.000786	0.00232	CcSEcCtD
Modafinil—Visual impairment—Methotrexate—esophageal cancer	0.000778	0.00229	CcSEcCtD
Modafinil—Confusional state—Capecitabine—esophageal cancer	0.000777	0.00229	CcSEcCtD
Modafinil—Oedema—Capecitabine—esophageal cancer	0.000771	0.00227	CcSEcCtD
Modafinil—Hypersensitivity—Cisplatin—esophageal cancer	0.00077	0.00227	CcSEcCtD
Modafinil—Infection—Capecitabine—esophageal cancer	0.000766	0.00226	CcSEcCtD
Modafinil—Erythema multiforme—Methotrexate—esophageal cancer	0.000763	0.00225	CcSEcCtD
Modafinil—Shock—Capecitabine—esophageal cancer	0.000758	0.00223	CcSEcCtD
Modafinil—Nervous system disorder—Capecitabine—esophageal cancer	0.000756	0.00223	CcSEcCtD
Modafinil—Tachycardia—Capecitabine—esophageal cancer	0.000752	0.00222	CcSEcCtD
Modafinil—Asthenia—Cisplatin—esophageal cancer	0.00075	0.00221	CcSEcCtD
Modafinil—Cardiac disorder—Methotrexate—esophageal cancer	0.000749	0.00221	CcSEcCtD
Modafinil—Skin disorder—Capecitabine—esophageal cancer	0.000749	0.00221	CcSEcCtD
Modafinil—Hyperhidrosis—Capecitabine—esophageal cancer	0.000745	0.00219	CcSEcCtD
Modafinil—Anorexia—Capecitabine—esophageal cancer	0.000735	0.00216	CcSEcCtD
Modafinil—Angiopathy—Methotrexate—esophageal cancer	0.000733	0.00216	CcSEcCtD
Modafinil—Immune system disorder—Methotrexate—esophageal cancer	0.000729	0.00215	CcSEcCtD
Modafinil—Mediastinal disorder—Methotrexate—esophageal cancer	0.000728	0.00214	CcSEcCtD
Modafinil—Methadone—CYP19A1—esophageal cancer	0.000725	0.0365	CrCbGaD
Modafinil—Chills—Methotrexate—esophageal cancer	0.000725	0.00213	CcSEcCtD
Modafinil—Hypotension—Capecitabine—esophageal cancer	0.00072	0.00212	CcSEcCtD
Modafinil—Diarrhoea—Cisplatin—esophageal cancer	0.000715	0.00211	CcSEcCtD
Modafinil—Mental disorder—Methotrexate—esophageal cancer	0.000707	0.00208	CcSEcCtD
Modafinil—Malnutrition—Methotrexate—esophageal cancer	0.000703	0.00207	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000702	0.00207	CcSEcCtD
Modafinil—Insomnia—Capecitabine—esophageal cancer	0.000697	0.00205	CcSEcCtD
Modafinil—Paraesthesia—Capecitabine—esophageal cancer	0.000692	0.00204	CcSEcCtD
Modafinil—Dysgeusia—Methotrexate—esophageal cancer	0.000688	0.00203	CcSEcCtD
Modafinil—Dyspnoea—Capecitabine—esophageal cancer	0.000687	0.00202	CcSEcCtD
Modafinil—Back pain—Methotrexate—esophageal cancer	0.00068	0.002	CcSEcCtD
Modafinil—Dyspepsia—Capecitabine—esophageal cancer	0.000678	0.002	CcSEcCtD
Modafinil—Decreased appetite—Capecitabine—esophageal cancer	0.00067	0.00197	CcSEcCtD
Modafinil—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000665	0.00196	CcSEcCtD
Modafinil—Vomiting—Cisplatin—esophageal cancer	0.000665	0.00196	CcSEcCtD
Modafinil—Fatigue—Capecitabine—esophageal cancer	0.000664	0.00196	CcSEcCtD
Modafinil—Rash—Cisplatin—esophageal cancer	0.000659	0.00194	CcSEcCtD
Modafinil—Pain—Capecitabine—esophageal cancer	0.000659	0.00194	CcSEcCtD
Modafinil—Constipation—Capecitabine—esophageal cancer	0.000659	0.00194	CcSEcCtD
Modafinil—Dermatitis—Cisplatin—esophageal cancer	0.000659	0.00194	CcSEcCtD
Modafinil—Ill-defined disorder—Methotrexate—esophageal cancer	0.000652	0.00192	CcSEcCtD
Modafinil—Anaemia—Methotrexate—esophageal cancer	0.00065	0.00191	CcSEcCtD
Modafinil—Feeling abnormal—Capecitabine—esophageal cancer	0.000635	0.00187	CcSEcCtD
Modafinil—Phenylbutazone—PTGS2—esophageal cancer	0.000634	0.0319	CrCbGaD
Modafinil—Malaise—Methotrexate—esophageal cancer	0.000634	0.00187	CcSEcCtD
Modafinil—Vertigo—Methotrexate—esophageal cancer	0.000632	0.00186	CcSEcCtD
Modafinil—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00063	0.00186	CcSEcCtD
Modafinil—Nausea—Cisplatin—esophageal cancer	0.000621	0.00183	CcSEcCtD
Modafinil—Cough—Methotrexate—esophageal cancer	0.000613	0.00181	CcSEcCtD
Modafinil—Urticaria—Capecitabine—esophageal cancer	0.000612	0.0018	CcSEcCtD
Modafinil—Body temperature increased—Capecitabine—esophageal cancer	0.000609	0.00179	CcSEcCtD
Modafinil—Abdominal pain—Capecitabine—esophageal cancer	0.000609	0.00179	CcSEcCtD
Modafinil—Convulsion—Methotrexate—esophageal cancer	0.000609	0.00179	CcSEcCtD
Modafinil—Diphenhydramine—PTGS1—esophageal cancer	0.000604	0.0304	CrCbGaD
Modafinil—Myalgia—Methotrexate—esophageal cancer	0.000598	0.00176	CcSEcCtD
Modafinil—Arthralgia—Methotrexate—esophageal cancer	0.000598	0.00176	CcSEcCtD
Modafinil—Chest pain—Methotrexate—esophageal cancer	0.000598	0.00176	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000594	0.00175	CcSEcCtD
Modafinil—Discomfort—Methotrexate—esophageal cancer	0.000591	0.00174	CcSEcCtD
Modafinil—Confusional state—Methotrexate—esophageal cancer	0.000578	0.0017	CcSEcCtD
Modafinil—Anaphylactic shock—Methotrexate—esophageal cancer	0.000574	0.00169	CcSEcCtD
Modafinil—Infection—Methotrexate—esophageal cancer	0.00057	0.00168	CcSEcCtD
Modafinil—Hypersensitivity—Capecitabine—esophageal cancer	0.000568	0.00167	CcSEcCtD
Modafinil—Nervous system disorder—Methotrexate—esophageal cancer	0.000563	0.00166	CcSEcCtD
Modafinil—Skin disorder—Methotrexate—esophageal cancer	0.000557	0.00164	CcSEcCtD
Modafinil—Hyperhidrosis—Methotrexate—esophageal cancer	0.000555	0.00163	CcSEcCtD
Modafinil—Asthenia—Capecitabine—esophageal cancer	0.000553	0.00163	CcSEcCtD
Modafinil—Anorexia—Methotrexate—esophageal cancer	0.000547	0.00161	CcSEcCtD
Modafinil—Pruritus—Capecitabine—esophageal cancer	0.000545	0.00161	CcSEcCtD
Modafinil—Hypotension—Methotrexate—esophageal cancer	0.000536	0.00158	CcSEcCtD
Modafinil—Diarrhoea—Capecitabine—esophageal cancer	0.000527	0.00155	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000523	0.00154	CcSEcCtD
Modafinil—Insomnia—Methotrexate—esophageal cancer	0.000519	0.00153	CcSEcCtD
Modafinil—Paraesthesia—Methotrexate—esophageal cancer	0.000515	0.00152	CcSEcCtD
Modafinil—Dyspnoea—Methotrexate—esophageal cancer	0.000511	0.00151	CcSEcCtD
Modafinil—Somnolence—Methotrexate—esophageal cancer	0.00051	0.0015	CcSEcCtD
Modafinil—Dizziness—Capecitabine—esophageal cancer	0.00051	0.0015	CcSEcCtD
Modafinil—Dyspepsia—Methotrexate—esophageal cancer	0.000505	0.00149	CcSEcCtD
Modafinil—Decreased appetite—Methotrexate—esophageal cancer	0.000499	0.00147	CcSEcCtD
Modafinil—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000495	0.00146	CcSEcCtD
Modafinil—Fatigue—Methotrexate—esophageal cancer	0.000495	0.00146	CcSEcCtD
Modafinil—Pain—Methotrexate—esophageal cancer	0.000491	0.00145	CcSEcCtD
Modafinil—Vomiting—Capecitabine—esophageal cancer	0.00049	0.00144	CcSEcCtD
Modafinil—Rash—Capecitabine—esophageal cancer	0.000486	0.00143	CcSEcCtD
Modafinil—Dermatitis—Capecitabine—esophageal cancer	0.000485	0.00143	CcSEcCtD
Modafinil—Headache—Capecitabine—esophageal cancer	0.000483	0.00142	CcSEcCtD
Modafinil—Feeling abnormal—Methotrexate—esophageal cancer	0.000473	0.00139	CcSEcCtD
Modafinil—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000469	0.00138	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—esophageal cancer	0.000468	0.0236	CrCbGaD
Modafinil—Nausea—Capecitabine—esophageal cancer	0.000458	0.00135	CcSEcCtD
Modafinil—Urticaria—Methotrexate—esophageal cancer	0.000456	0.00134	CcSEcCtD
Modafinil—Abdominal pain—Methotrexate—esophageal cancer	0.000453	0.00134	CcSEcCtD
Modafinil—Body temperature increased—Methotrexate—esophageal cancer	0.000453	0.00134	CcSEcCtD
Modafinil—Hypersensitivity—Methotrexate—esophageal cancer	0.000423	0.00125	CcSEcCtD
Modafinil—Fentanyl—ABCB1—esophageal cancer	0.000413	0.0208	CrCbGaD
Modafinil—Asthenia—Methotrexate—esophageal cancer	0.000412	0.00121	CcSEcCtD
Modafinil—Pruritus—Methotrexate—esophageal cancer	0.000406	0.0012	CcSEcCtD
Modafinil—Diarrhoea—Methotrexate—esophageal cancer	0.000393	0.00116	CcSEcCtD
Modafinil—Carbamazepine—ABCB1—esophageal cancer	0.000385	0.0194	CrCbGaD
Modafinil—Dizziness—Methotrexate—esophageal cancer	0.000379	0.00112	CcSEcCtD
Modafinil—Phenytoin—ABCB1—esophageal cancer	0.000375	0.0189	CrCbGaD
Modafinil—Vomiting—Methotrexate—esophageal cancer	0.000365	0.00107	CcSEcCtD
Modafinil—Rash—Methotrexate—esophageal cancer	0.000362	0.00107	CcSEcCtD
Modafinil—Dermatitis—Methotrexate—esophageal cancer	0.000361	0.00106	CcSEcCtD
Modafinil—Headache—Methotrexate—esophageal cancer	0.000359	0.00106	CcSEcCtD
Modafinil—Nausea—Methotrexate—esophageal cancer	0.000341	0.001	CcSEcCtD
Modafinil—Methadone—ABCB1—esophageal cancer	0.000283	0.0143	CrCbGaD
Modafinil—CYP2B6—Metabolism—ADH7—esophageal cancer	0.000131	0.000371	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CSNK1A1—esophageal cancer	0.00013	0.00037	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—ANXA1—esophageal cancer	0.000129	0.000366	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000128	0.000363	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000128	0.000363	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—SST—esophageal cancer	0.000126	0.000356	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000124	0.000353	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000124	0.000353	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000124	0.000351	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—GHRL—esophageal cancer	0.000122	0.000347	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000122	0.000347	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PFN1—esophageal cancer	0.000122	0.000346	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.00012	0.00034	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00012	0.00034	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CA1—esophageal cancer	0.000116	0.00033	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000116	0.00033	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ADH1B—esophageal cancer	0.000115	0.000325	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000112	0.000318	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000111	0.000316	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TYMP—esophageal cancer	0.000109	0.000311	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ELMO1—esophageal cancer	0.000109	0.000311	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000107	0.000304	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000107	0.000304	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKAP13—esophageal cancer	0.000107	0.000304	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000107	0.000303	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP26A1—esophageal cancer	0.000106	0.000302	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000106	0.000302	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000106	0.000302	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CA2—esophageal cancer	0.000106	0.000301	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000106	0.000301	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CA1—esophageal cancer	0.000106	0.000301	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000104	0.000296	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000104	0.000295	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALOX15—esophageal cancer	0.000104	0.000295	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000101	0.000288	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTO1—esophageal cancer	9.9e-05	0.000281	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TPI1—esophageal cancer	9.9e-05	0.000281	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIST1H2BM—esophageal cancer	9.87e-05	0.00028	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PLCE1—esophageal cancer	9.87e-05	0.00028	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ADH7—esophageal cancer	9.87e-05	0.00028	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PDE4D—esophageal cancer	9.78e-05	0.000278	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.76e-05	0.000277	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CA2—esophageal cancer	9.68e-05	0.000275	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TPI1—esophageal cancer	9.68e-05	0.000275	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTO1—esophageal cancer	9.68e-05	0.000275	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	9.51e-05	0.00027	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALDOB—esophageal cancer	9.49e-05	0.000269	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	9.46e-05	0.000269	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GNG7—esophageal cancer	9.31e-05	0.000264	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALDOB—esophageal cancer	9.28e-05	0.000263	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GAPDH—esophageal cancer	9.14e-05	0.000259	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CRABP1—esophageal cancer	9.05e-05	0.000257	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CA1—esophageal cancer	9.05e-05	0.000257	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC10A2—esophageal cancer	9.05e-05	0.000257	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PLCE1—esophageal cancer	9e-05	0.000256	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ADH7—esophageal cancer	9e-05	0.000256	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GAPDH—esophageal cancer	8.93e-05	0.000254	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.9e-05	0.000253	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CRABP1—esophageal cancer	8.85e-05	0.000251	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—XIAP—esophageal cancer	8.72e-05	0.000248	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ADH1B—esophageal cancer	8.66e-05	0.000246	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GNG7—esophageal cancer	8.61e-05	0.000245	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GNG7—esophageal cancer	8.42e-05	0.000239	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CA2—esophageal cancer	8.27e-05	0.000235	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TYMP—esophageal cancer	8.27e-05	0.000235	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNA1—esophageal cancer	8.25e-05	0.000234	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC52A3—esophageal cancer	8.21e-05	0.000233	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BLVRB—esophageal cancer	8.21e-05	0.000233	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL2—esophageal cancer	8.2e-05	0.000233	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	8.09e-05	0.00023	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ALDH2—esophageal cancer	8.07e-05	0.000229	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP26A1—esophageal cancer	8.05e-05	0.000228	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ADH1B—esophageal cancer	7.89e-05	0.000224	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ALDH2—esophageal cancer	7.89e-05	0.000224	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALOX15—esophageal cancer	7.84e-05	0.000223	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PLCE1—esophageal cancer	7.69e-05	0.000218	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ADH7—esophageal cancer	7.69e-05	0.000218	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTT1—esophageal cancer	7.68e-05	0.000218	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PSME2—esophageal cancer	7.66e-05	0.000217	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PSME1—esophageal cancer	7.66e-05	0.000217	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ANXA1—esophageal cancer	7.62e-05	0.000216	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	7.6e-05	0.000216	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP2A6—esophageal cancer	7.59e-05	0.000215	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TYMP—esophageal cancer	7.54e-05	0.000214	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTT1—esophageal cancer	7.5e-05	0.000213	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TPI1—esophageal cancer	7.48e-05	0.000212	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTO1—esophageal cancer	7.48e-05	0.000212	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP2A6—esophageal cancer	7.42e-05	0.000211	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SST—esophageal cancer	7.41e-05	0.000211	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP26A1—esophageal cancer	7.34e-05	0.000208	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH3—esophageal cancer	7.23e-05	0.000205	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GHRL—esophageal cancer	7.23e-05	0.000205	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ENO1—esophageal cancer	7.19e-05	0.000204	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS1—esophageal cancer	7.19e-05	0.000204	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALDOB—esophageal cancer	7.17e-05	0.000204	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALOX15—esophageal cancer	7.15e-05	0.000203	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FBXW7—esophageal cancer	7.11e-05	0.000202	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PSME2—esophageal cancer	7.09e-05	0.000201	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PSME1—esophageal cancer	7.09e-05	0.000201	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS1—esophageal cancer	7.03e-05	0.0002	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ENO1—esophageal cancer	7.03e-05	0.0002	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC10A2—esophageal cancer	6.98e-05	0.000198	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CA1—esophageal cancer	6.98e-05	0.000198	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PSME1—esophageal cancer	6.93e-05	0.000197	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PSME2—esophageal cancer	6.93e-05	0.000197	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GAPDH—esophageal cancer	6.9e-05	0.000196	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CRABP1—esophageal cancer	6.84e-05	0.000194	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTO1—esophageal cancer	6.82e-05	0.000194	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TPI1—esophageal cancer	6.82e-05	0.000194	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ADH1B—esophageal cancer	6.74e-05	0.000191	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALDOB—esophageal cancer	6.54e-05	0.000186	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GNG7—esophageal cancer	6.51e-05	0.000185	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH2—esophageal cancer	6.48e-05	0.000184	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TYMP—esophageal cancer	6.44e-05	0.000183	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CA2—esophageal cancer	6.38e-05	0.000181	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GAPDH—esophageal cancer	6.29e-05	0.000179	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP26A1—esophageal cancer	6.27e-05	0.000178	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CRABP1—esophageal cancer	6.24e-05	0.000177	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1B1—esophageal cancer	6.12e-05	0.000174	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALOX15—esophageal cancer	6.11e-05	0.000173	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALDH2—esophageal cancer	6.1e-05	0.000173	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1B1—esophageal cancer	5.98e-05	0.00017	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ADH7—esophageal cancer	5.94e-05	0.000169	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PLCE1—esophageal cancer	5.94e-05	0.000169	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GNG7—esophageal cancer	5.93e-05	0.000168	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTO1—esophageal cancer	5.83e-05	0.000166	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TPI1—esophageal cancer	5.83e-05	0.000166	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTT1—esophageal cancer	5.8e-05	0.000165	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP19A1—esophageal cancer	5.75e-05	0.000163	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFBR2—esophageal cancer	5.75e-05	0.000163	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP2A6—esophageal cancer	5.73e-05	0.000163	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.71e-05	0.000162	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP19A1—esophageal cancer	5.62e-05	0.00016	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALDOB—esophageal cancer	5.59e-05	0.000159	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALDH2—esophageal cancer	5.56e-05	0.000158	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SMAD4—esophageal cancer	5.44e-05	0.000155	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS1—esophageal cancer	5.44e-05	0.000154	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ENO1—esophageal cancer	5.44e-05	0.000154	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GAPDH—esophageal cancer	5.38e-05	0.000153	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PSME2—esophageal cancer	5.36e-05	0.000152	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PSME1—esophageal cancer	5.36e-05	0.000152	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CRABP1—esophageal cancer	5.33e-05	0.000151	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTT1—esophageal cancer	5.29e-05	0.00015	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—HMOX1—esophageal cancer	5.25e-05	0.000149	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2A6—esophageal cancer	5.23e-05	0.000148	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.21e-05	0.000148	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ADH1B—esophageal cancer	5.2e-05	0.000148	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—HMOX1—esophageal cancer	5.13e-05	0.000146	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GNG7—esophageal cancer	5.07e-05	0.000144	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCB1—esophageal cancer	5.04e-05	0.000143	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TYMP—esophageal cancer	4.97e-05	0.000141	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ENO1—esophageal cancer	4.96e-05	0.000141	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS1—esophageal cancer	4.96e-05	0.000141	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCB1—esophageal cancer	4.92e-05	0.00014	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PSME2—esophageal cancer	4.88e-05	0.000139	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PSME1—esophageal cancer	4.88e-05	0.000139	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.84e-05	0.000137	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALDH2—esophageal cancer	4.75e-05	0.000135	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.72e-05	0.000134	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.68e-05	0.000133	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1B1—esophageal cancer	4.62e-05	0.000131	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTT1—esophageal cancer	4.52e-05	0.000128	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TPI1—esophageal cancer	4.5e-05	0.000128	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.5e-05	0.000128	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2A6—esophageal cancer	4.47e-05	0.000127	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIF1A—esophageal cancer	4.45e-05	0.000126	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.45e-05	0.000126	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP19A1—esophageal cancer	4.35e-05	0.000123	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.31e-05	0.000122	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.26e-05	0.000121	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KDR—esophageal cancer	4.26e-05	0.000121	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS1—esophageal cancer	4.23e-05	0.00012	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ENO1—esophageal cancer	4.23e-05	0.00012	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1B1—esophageal cancer	4.21e-05	0.00012	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PSME2—esophageal cancer	4.17e-05	0.000118	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PSME1—esophageal cancer	4.17e-05	0.000118	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.15e-05	0.000118	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.11e-05	0.000117	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOTCH1—esophageal cancer	4.01e-05	0.000114	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—HMOX1—esophageal cancer	3.96e-05	0.000113	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP19A1—esophageal cancer	3.96e-05	0.000113	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GNG7—esophageal cancer	3.91e-05	0.000111	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.89e-05	0.00011	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCB1—esophageal cancer	3.81e-05	0.000108	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.67e-05	0.000104	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.64e-05	0.000103	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CREBBP—esophageal cancer	3.64e-05	0.000103	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—HMOX1—esophageal cancer	3.62e-05	0.000103	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1B1—esophageal cancer	3.6e-05	0.000102	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—esophageal cancer	3.57e-05	0.000101	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.55e-05	0.000101	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.49e-05	9.9e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCB1—esophageal cancer	3.47e-05	9.85e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.45e-05	9.79e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—esophageal cancer	3.42e-05	9.7e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP19A1—esophageal cancer	3.39e-05	9.61e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CREBBP—esophageal cancer	3.37e-05	9.56e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CREBBP—esophageal cancer	3.29e-05	9.34e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ENO1—esophageal cancer	3.27e-05	9.28e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.27e-05	9.28e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOS3—esophageal cancer	3.26e-05	9.25e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PSME2—esophageal cancer	3.22e-05	9.15e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PSME1—esophageal cancer	3.22e-05	9.15e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—esophageal cancer	3.1e-05	8.81e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—HMOX1—esophageal cancer	3.09e-05	8.77e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB2—esophageal cancer	3.05e-05	8.65e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.03e-05	8.61e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NOS3—esophageal cancer	3.01e-05	8.56e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCB1—esophageal cancer	2.97e-05	8.42e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NOS3—esophageal cancer	2.95e-05	8.36e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.88e-05	8.17e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.78e-05	7.89e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—esophageal cancer	2.76e-05	7.83e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—esophageal cancer	2.69e-05	7.65e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	2.69e-05	7.64e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.62e-05	7.45e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.61e-05	7.42e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	2.6e-05	7.39e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CREBBP—esophageal cancer	2.54e-05	7.22e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EP300—esophageal cancer	2.48e-05	7.03e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.38e-05	6.77e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CREBBP—esophageal cancer	2.32e-05	6.59e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—EP300—esophageal cancer	2.29e-05	6.51e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.29e-05	6.5e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NOS3—esophageal cancer	2.28e-05	6.47e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.24e-05	6.37e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—EP300—esophageal cancer	2.24e-05	6.36e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—esophageal cancer	2.16e-05	6.13e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	2.11e-05	6e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.08e-05	5.91e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NOS3—esophageal cancer	2.08e-05	5.9e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.98e-05	5.63e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.9e-05	5.39e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	1.83e-05	5.2e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NOS3—esophageal cancer	1.77e-05	5.04e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—esophageal cancer	1.77e-05	5.03e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—EP300—esophageal cancer	1.73e-05	4.92e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—esophageal cancer	1.7e-05	4.82e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.66e-05	4.71e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.62e-05	4.61e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—EP300—esophageal cancer	1.58e-05	4.49e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.53e-05	4.34e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NOS3—esophageal cancer	1.37e-05	3.89e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—EP300—esophageal cancer	1.35e-05	3.83e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.28e-05	3.64e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.25e-05	3.56e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.17e-05	3.32e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—EP300—esophageal cancer	1.04e-05	2.96e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—esophageal cancer	9.98e-06	2.84e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—esophageal cancer	7.71e-06	2.19e-05	CbGpPWpGaD
